Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05863754 · ClinicalTrials.gov registry record · NA

Grasp-Release Assessment of a Networked Neuroprosthesis Device

A NA study of Spinal Cord Injuries and Spinal Cord Injury Cervical, sponsored by MetroHealth Medical Center.

Recruiting
Registry status
NA
Development phase
13
Enrollment target
1
Study location

NCT05863754: Recruiting NA study of Spinal Cord Injuries and Spinal Cord Injury Cervical, sponsored by MetroHealth Medical Center.

NCT05863754 is a NA study of Spinal Cord Injuries and Spinal Cord Injury Cervical that is actively recruiting participants, run by MetroHealth Medical Center. The registered enrollment target is 13 participants, below the 62-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05863754, a NA study of Spinal Cord Injuries and Spinal Cord Injury Cervical, is actively recruiting participants, sponsored by MetroHealth Medical Center.

RECRUITING
Registry status
NA
Development phase
13 participants
Enrollment target
1
Study location

Study Summary

The overall objective of this trial is to characterize the safety and effectiveness of the Networked Neuroprosthesis Device - Upper Extremity (NP-UE) in individuals living with cervical SCI.

Primary Outcome

Ability to pick up, move, and release six standard objects

Conditions Studied

Spinal Cord Injuries Spinal Cord Injury Cervical Spinal Cord Injury at C5-C7 Level

Interventions

  • DEVICE Networked Neuroprosthesis Device

Study Locations (1)

Ohio

  • MetroHealth Medical Center - Cleveland

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2022-01-23
Est. Completion 2028-12-01
Phase NA
MetroHealth Medical Center

76 total trials

What NCT05863754 shows while recruiting

NCT05863754 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 62-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (79% lower).

The record links to 3 conditions, with Spinal Cord Injuries appearing as the primary indexed condition, and to 1 intervention - of which Networked Neuroprosthesis Device is the first listed.

NCT05863754 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT05863754 about?

NCT05863754 is a clinical study titled "Grasp-Release Assessment of a Networked Neuroprosthesis Device". The overall objective of this trial is to characterize the safety and effectiveness of the Networked Neuroprosthesis Device - Upper Extremity (NP-UE) in individuals living with cervical SCI.

What is the current status of trial NCT05863754?

This trial is currently recruiting. It is a NA study. The enrollment target is 13 participants. The study started on 2022-01-23. Estimated completion is 2028-12-01.

What conditions does trial NCT05863754 study?

This clinical trial studies the following conditions: Spinal Cord Injuries, Spinal Cord Injury Cervical, Spinal Cord Injury at C5-C7 Level.

What interventions are being tested in trial NCT05863754?

The interventions under investigation include: Networked Neuroprosthesis Device (DEVICE).

Who is sponsoring clinical trial NCT05863754?

This trial is sponsored by MetroHealth Medical Center, which has 76 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05863754 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Spinal Cord Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05863754's enrollment target sits among peer trials

13 162nd of 202 higher than 39 of 202 other Spinal Cord Injuries trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Spinal Cord Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03125655 · 13 participants

    Regulation of Inflammatory Genes in Psoriasis

  • NCT03774446 · 13 participants · Phase 2

    Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease

  • NCT03830151 · 13 participants · Phase 1

    Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors

  • NCT04573231 · 13 participants · Phase 2

    Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

More recruiting context for NCT05863754

Source: ClinicalTrials.gov NCT05863754, the US trial registry maintained by the National Library of Medicine. NCT05863754 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.